Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Amy E. Weber is active.

Publication


Featured researches published by Amy E. Weber.


AIDS | 2001

Increasing incidence of HIV infections among young gay and biseuxal men in Vancouver

Robert S. Hogg; Amy E. Weber; Keith C. C. Chan; Steve Martindale; Darrel Cook; Mary Lou Miller; Kevin J. P. Craib

Since the beginning of the HIV epidemic in north America, the majority of HIV infections have occurred among men who engage in sexual relations with other men. As the HIV epidemic enters its third decade, gay and bisexual men continue to have among the highest rates of HIV infection. Previous studies have highlighted the decline in the incidence of HIV and risk behaviour among gay and bisexual men. However, several studies have suggested that young gay and bisexual men continue to engage in unprotected sexual behaviours and are at continued risk of HIV infection. Recent reports in the media and research literature have indicated an increase in the incidence of HIV among gay and bisexual individuals in many of the worlds major cities. The purpose of this study was to determine trends in HIV incidence using data from a prospective cohort of young gay and bisexual men.


Journal of Acquired Immune Deficiency Syndromes | 2001

Risk factors associated with HIV infection among young gay and bisexual men in Canada

Amy E. Weber; Keith Chan; Clemon George; Robert S. Hogg; Robert S. Remis; Steve Martindale; Joanne Otis; Mary Lou Miller; Jean Vincelette; Kevin J. P. Craib; Benoît Mâsse; Martin T. Schechter; Roger LeClerc; René Lavoie; Bruno Turmel; Raymond Parent; Michel Alary

Objective: To assess risk factors associated with HIV prevalence and incidence among gay and bisexual men in two prospective Canadian cohorts. Methods: The Vanguard Project and the Omega Cohort are prospective cohort studies of gay and bisexual men ongoing in Vancouver and Montreal, respectively. For this analysis, baseline sociodemographic characteristics, sexual behavior, and substance use data from these two cohorts were combined. Assessment of risk factors for HIV seroprevalence and seroconversion were carried out using univariate and multivariate analysis. Results: This analysis was based on 1373 gay and bisexual men aged 16 to 30 years. Men who were HIV‐seropositive at baseline (n = 48) were more likely to report living in unstable housing, to have had less than a high school education, and to have been unemployed than those who were HIV‐negative (n = 1325). HIV‐positive men were also more likely to report having engaged in sexual risk behavior, including having had consensual sex at a younger age, having had at least 6 partners during the previous year, ever having been involved in the sex trade, and having engaged in unprotected receptive anal intercourse. With respect to substance use, HIV‐positive men were more likely to report the use of crack, cocaine, heroin, and marijuana and to use injection drugs. Similarly, men who seroconverted during the course of the studies (n = 26) were more likely to report having less than a high school education and having lived in unstable housing at baseline. Compared with HIV‐negative men, men who seroconverted were more likely to report ever having been involved in the sex trade and engaging in unprotected receptive anal intercourse. Reports of cocaine use and injection drug use were also significantly higher for men who seroconverted compared with HIV‐negative men. Conclusions: Our data indicate that HIV‐positive gay and bisexual men are more likely to be living in unstable conditions and to report more risky sexual and substance use behaviors than HIV‐negative men.


AIDS | 1998

One world one hope: the cost of providing antiretroviral therapy to all nations.

Robert S. Hogg; Amy E. Weber; K. J. P. Craib; Aslam H. Anis; M. V. O'shaughnessy; Martin T. Schechter; Julio S. G. Montaner

Objective:To estimate the potential direct cost of making triple combination antiretroviral therapy widely available to HIV-positive adults and children living in countries throughout the world. Methods:For each country, antiretroviral costs were obtained by multiplying the annual cost of triple antiretroviral therapy by the estimated number of HIV-positive persons accessing therapy. Per capita antiretroviral costs were computed by dividing the antiretroviral costs by the countrys total population. The potential economic burden was calculated by dividing per capita antiretroviral costs by the gross national product (GNP) per capita. All values are expressed in 1997 US dollars. Results:The potential cost of making triple combination antiretroviral therapy available to HIV-positive individuals throughout the world was estimated to be over US


Aids and Behavior | 2004

Sexual Risk Profile of Young Men in Vancouver, British Columbia, Who Have Sex with Men and Inject Drugs

Jacqueline M. O'connell; Thomas M. Lampinen; Amy E. Weber; Keith Chan; Mary Lou Miller; Martin T. Schechter; Robert S. Hogg

65.8 billion. By far the greatest financial burden was on sub-Saharan Africa. The highest per capita drug cost in this region would be incurred in the subregions of Southern Africa (US


Journal of Acquired Immune Deficiency Syndromes | 2001

Longitudinal patterns of sexual behavior and condom use in a cohort of HIV-negative gay and bisexual men in Vancouver, British Columbia, Canada, 1995-2000.

Magdalena A. Piaseczna; Kevin J. P. Craib; Kathy Li; Keith Chan; Amy E. Weber; Steffanie A. Strathdee; Steve Martindale; Martin T. Schechter; Robert S. Hogg

149) followed by East Africa (US


Canadian Journal of Public Health-revue Canadienne De Sante Publique | 1999

Morbidity and mortality related to human immunodeficiency virus in Canadian men and women, 1987-94.

Amy E. Weber; Robert S. Hogg

116), Middle Africa (US


Annals of Epidemiology | 2003

High-Risk behaviours among men having sex with other men (MSM) who were born in Canada compared to those who immigrated to Canada-what should we measure?

Clemon George; Michel Alary; Robert S. Hogg; Robert S. Remis; Joanne Otis; Benoît Mâsse; Bruno Turmel; Roger LeClerc; René Lavoie; Jean Vincelette; Raymond Parent; Keith Chan; Steve Martindale; Mary Lou Miller; Kevin J. P. Craib; M.T. Schecter; Amy E. Weber

44), and West Africa (US


International Journal of Epidemiology | 2001

Sex trade involvement and rates of human immunodeficiency virus positivity among young gay and bisexual men

Amy E. Weber; Kevin J. P. Craib; Keith Chan; Steve Martindale; Mary Lou Miller; Martin T. Schechter; Robert S. Hogg

42). In the Americas, subregional data indicated the highest per capita drug cost would be in the Latin Caribbean (US


AIDS | 2003

HIV incidence among street youth in Montreal, Canada.

Élise Roy; Nancy Haley; Pascale Leclerc; Lyne Cédras; Amy E. Weber; Christiane Claessens; Jean-François Boivin

22), followed by the Caribbean (US


AIDS | 2003

Determinants of HIV serconversion in an era of increasing HIV infection among young gay and bisexual men.

Amy E. Weber; Kevin J. P. Craib; Keith Chan; Steve Martindale; Mary Lou Miller; Darrel Cook; Martin T. Schechter; Robert S. Hogg

17), Andean Area (US

Collaboration


Dive into the Amy E. Weber's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Martin T. Schechter

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Kevin J. P. Craib

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Julio S. G. Montaner

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Aslam H. Anis

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Benoît Mâsse

Université de Montréal

View shared research outputs
Researchain Logo
Decentralizing Knowledge